5-oxo-prolyl-glycyl-arginine-4-nitroanilide has been researched along with glycosides in 1 studies
| Studies (5-oxo-prolyl-glycyl-arginine-4-nitroanilide) | Trials (5-oxo-prolyl-glycyl-arginine-4-nitroanilide) | Recent Studies (post-2010) (5-oxo-prolyl-glycyl-arginine-4-nitroanilide) | Studies (glycosides) | Trials (glycosides) | Recent Studies (post-2010) (glycosides) |
|---|---|---|---|---|---|
| 26 | 0 | 1 | 20,179 | 169 | 6,844 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Henningsson, F; Kimata, K; Kolset, SO; Pejler, G; Uhlin-Hansen, L; Vuong, TT; Winberg, JO | 1 |
1 other study(ies) available for 5-oxo-prolyl-glycyl-arginine-4-nitroanilide and glycosides
| Article | Year |
|---|---|
Secretion of macrophage urokinase plasminogen activator is dependent on proteoglycans.
Topics: Amiloride; Animals; Cells, Cultured; Glycosides; Macrophages; Matrix Metalloproteinase 9; Mice; Microscopy, Electron; Oligopeptides; Plasminogen Activator Inhibitor 1; Proteoglycans; Serine Endopeptidases; Tetradecanoylphorbol Acetate; Urokinase-Type Plasminogen Activator | 2003 |